# Leukemia, Lymphocytic studies recruiting: 50 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 50 trials that are observational for Leukemia, Lymphocytic, Chronic, B-Cell that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Leukemia, Lymphocytic, Chronic, B-Cell studies: 50 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/leukemia-lymphocytic-chronic-b-cell

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 50
- Recruiting or not yet: 50
- Read on: November 19, 2026

## Trials

The 25 newest of 50, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 20, 2026 | NCT07882732 | RPM Signals in Outpatient CAR T Therapy | Current Health | Observational | Not yet recruiting | Cytokine Release Syndrome, Immune Effector Cell-Associated Neurotoxicity Syndrome, B-Cell Lymphoma, Chronic Lymphocytic... | 125 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07882732) |
| August 19, 2026 | NCT07774390 | Ibrutinib Plus Venetoclax Long-Term Outcomes in CLL | European Research Initiative on CLL | Observational | Recruiting | Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) | 323 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07774390) |
| August 13, 2026 | NCT07763054 | Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients | Haikou Affiliated Hospital of Central South University Xiangya School of Medicine | Observational | Recruiting | Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Lymphoma, Multiple Myeloma, Chronic... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07763054) |
| August 12, 2026 | NCT07759661 | Innovative 3D Preclinical Models for Mature B-cell Malignancies to Advance Personalized Immuno and Combination Therapies | IRCCS San Raffaele | Observational | Not yet recruiting | Chronic Lymphocytic Leukemia (CLL), Splenic Marginal Zone Lymphoma, Hairy Cell Leukemia (HCL) | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07759661) |
| August 3, 2026 | NCT07741695 | Targeting IRAK4 in Chronic Lymphocytic Leukemia | IRCCS San Raffaele | Observational | Not yet recruiting | Chronic Lymphocytic Leukemia (CLL) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07741695) |
| July 17, 2026 | NCT07711327 | Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy | Sponsor not shown (see the record) | Observational | Not yet recruiting | Atrial Fibrillation (AF), Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia, Mantle Cell Lymphoma, Marginal... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07711327) |
| June 10, 2026 | NCT07638007 | Impact of Targeted Therapy on Cancer-Related Cognitive Impairment | University of Rochester NCORP Research Base | Observational | Recruiting | Disease/Condition Name Cancer-related Cognitive Dysfunction, Chronic Lymphocytic Leukemia (CLL), Chronic Myeloid... | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07638007) |
| May 22, 2026 | NCT07602088 | A Real-world Study of Ibrutinib and Venetoclax (I+V) First-Line Treatment Given for Fixed-duration of Time in Participants With Chronic... | Janssen Research & Development, LLC | Observational | Recruiting | Leukemia, Lymphocytic, Chronic, B-Cell | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07602088) |
| March 11, 2026 | NCT07463976 | variaTIon in Referral Thresholds in the Chronic Lymphocytic LeukaEmia Pathway | The Royal Wolverhampton Hospitals NHS Trust | Observational | Not yet recruiting | Chronic Lymphocytic Leukemia, Haematological Malignancy | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07463976) |
| January 2, 2026 | NCT07313982 | LEF1 EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A MARKER FOR DIAGNOSIS AND SURVIVAL PREDICTION | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Observational | Recruiting | Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) | 350 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07313982) |
| December 17, 2025 | NCT07288515 | Observ Prosp Study of Acalabrutinib in CLL Therapy in Real Clinical Practice in Belarus | AstraZeneca | Observational | Recruiting | Chronic Lymphocytic Leukemia | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07288515) |
| September 9, 2025 | NCT07162532 | Clinico-hematological and Molecular Characteristics of Chronic Lymphocytic Leukemia Patients | Assiut University | Observational | Not yet recruiting | Chronic Lymphocytic Leukemia (CLL) | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07162532) |
| September 5, 2025 | NCT07157579 | Notch 1 Mutation in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patient | Sohag University | Observational | Not yet recruiting | Chronic Lymphocytic Leukemia (CLL)- Non-Hodgins's Lymphoma (NHL) | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07157579) |
| August 28, 2025 | NCT07145411 | HPC Offered for PRESERVE Expansion | Ossium Health, Inc. | Observational | Recruiting | Bone Marrow Transplant (BMT) | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07145411) |
| August 8, 2025 | NCT07113132 | Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia | Sponsor not shown (see the record) | Observational | Not yet recruiting | Acute Lymphoblastic Leukemia ALL, Chronic Lymphocytic Leukemia (CLL) | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07113132) |
| August 1, 2025 | NCT07099443 | Determinants of the Response to BTK Degraders (BTKd) in Chronic Lymphocytic Leukemia | Nantes University Hospital | Observational | Recruiting | Chronic Lymphocytic Leukemia, BTK Degraders | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07099443) |
| June 22, 2025 | NCT07030400 | Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma | H. Lee Moffitt Cancer Center and Research Institute | Observational | Recruiting | Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07030400) |
| January 27, 2025 | NCT06792994 | A Prospective Observational Trial to Assess Treatment Sequences and Factors That Impact Overall Sur-vival in Patients With Chronic... | German CLL Study Group | Observational | Recruiting | Chronic Lymphocytic Leukemia | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06792994) |
| January 23, 2025 | NCT06788639 | A Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel... | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | Observational | Recruiting | Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06788639) |
| January 20, 2025 | NCT06784167 | Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment | OHSU Knight Cancer Institute | Observational | Recruiting | Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Multiple... | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06784167) |
| August 12, 2024 | NCT06548152 | AQUALIS:QoL of CLL Patients Treated With Acalabrutinib in France, Retrospective Study Based on Data From PLATON Database | AstraZeneca | Observational | Recruiting | Chronic Lymphocytic Leukemia | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06548152) |
| August 5, 2024 | NCT06536452 | Hematopoiesis in MBL and CLL Versus Healthy Age-Matched Control Subjects | Mayo Clinic | Observational | Recruiting | Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06536452) |
| May 16, 2024 | NCT06416267 | Risk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL) | University of Haifa | Observational | Not yet recruiting | Monoclonal B-Cell Lymphocytosis, Chronic Lymphocytic Leukemia, Infections, Cancers, Cardiovascular Diseases, Alzheimer... | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06416267) |
| March 8, 2024 | NCT06299540 | Benefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic Leukemia | Janssen Cilag S.A.S. | Observational | Recruiting | Leukemia, Lymphocytic, Chronic, B-Cell | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06299540) |
| January 25, 2024 | NCT06224309 | Preliminary Assessment of \[18F\]BL40 in PET/CT Scans | British Columbia Cancer Agency | Observational | Recruiting | Diffuse Large B-cell Lymphoma, Multiple Myeloma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Chronic Lymphocytic... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06224309) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 3 |
| Mayo Clinic | 3 |
| Dana-Farber Cancer Institute | 3 |
| [iOMEDICO AG](https://specstream.ai/data/clinical-trials/company/iomedico-ag) | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| IRCCS San Raffaele | 2 |
| University of Haifa | 2 |
| Ruijin Hospital | 1 |
| OHSU Knight Cancer Institute | 1 |
| Canadian Cancer Trials Group | 1 |
| Current Health | 1 |
| Janssen Cilag S.A.S. | 1 |
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 1 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 1 |
| University of Rochester NCORP Research Base | 1 |
| Institut Paoli-Calmettes | 1 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 1 |
| University of Wisconsin, Madison | 1 |
| European Research Initiative on CLL | 1 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 1 |
| Wake Forest University Health Sciences | 1 |
| Haikou Affiliated Hospital of Central South University Xiangya School of Medicine | 1 |
| The Royal Wolverhampton Hospitals NHS Trust | 1 |
| Emory University | 1 |
| Ossium Health, Inc. | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 22 |
| France | 5 |
| Germany | 4 |
| Italy | 4 |
| Austria | 2 |
| Canada | 2 |
| Spain | 1 |
| Switzerland | 1 |
| Romania | 1 |
| China | 1 |
| United Kingdom | 1 |
| Belarus | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Gastropubs in the United States](https://specstream.ai/data/businesses/gastropubs/united-states)
- [Child care centers in the United States](https://specstream.ai/data/businesses/child-care-centers/united-states)
- [Window installers in the United States](https://specstream.ai/data/businesses/window-installers/united-states)
- [Rail services in the United States](https://specstream.ai/data/businesses/rail-services/united-states)
- [Life insurance agencies in the United States](https://specstream.ai/data/businesses/life-insurance-agencies/united-states)
- [Estate planning law firms in the United States](https://specstream.ai/data/businesses/estate-planning-law-firms/united-states)
